Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1631-1640 of 1,873) with videos related to

Pageof 188
Sort By:
Journal of Patient-Reported Outcomes|August 22, 2025
Patient-reported outcomes and home-based self-swabs for influenza-like illness events - lessons learned from the 2023/2024 DANFLU-2 Homeswab PRO substudyFilip Soeskov Davidovski, Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, et al.
Journal of Cardiac Failure|March 7, 2023
Missense Genetic Variation of ICAM1 and Incident Heart FailurePedro Giro, Jonathan W Cunningham, Laura Rasmussen-Torvik, et al.
European Journal of Heart Failure|May 3, 2024
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fractionMingming Yang, Toru Kondo, Atefeh Talebi, et al.
Journal of the American College of Cardiology|December 10, 2025
Myocardial Amyloid Burden in Transthyretin AmyloidosisAwais Sheikh, Anouk Achten, Alberto Aimo, et al.
NEJM Evidence|February 6, 2024
A Pragmatic Randomized Feasibility Trial of Influenza VaccinesNiklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
Circulation. Heart Failure|October 27, 2023
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVERToru Kondo, Jawad H Butt, James P Curtain, et al.
European Heart Journal|March 4, 2026
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term studyAlbree Tower-Rader, Ahmad Masri, Michael E Nassif, et al.
JAMA Cardiology|March 28, 2026
Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical TrialHenri Lu, Annamaria Kosztin, Brian L Claggett, et al.
JACC. Heart Failure|September 28, 2023
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER TrialAlexander Peikert, Bradley A Bart, Muthiah Vaduganathan, et al.
JACC. Heart Failure|November 17, 2020
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
Pageof 188

Showing results (1631-1640 of 1,873) with videos related to

Sort By:
Pageof 188
Journal of Patient-Reported Outcomes|August 22, 2025
Patient-reported outcomes and home-based self-swabs for influenza-like illness events - lessons learned from the 2023/2024 DANFLU-2 Homeswab PRO substudyFilip Soeskov Davidovski, Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, et al.
Journal of Cardiac Failure|March 7, 2023
Missense Genetic Variation of ICAM1 and Incident Heart FailurePedro Giro, Jonathan W Cunningham, Laura Rasmussen-Torvik, et al.
European Journal of Heart Failure|May 3, 2024
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fractionMingming Yang, Toru Kondo, Atefeh Talebi, et al.
Journal of the American College of Cardiology|December 10, 2025
Myocardial Amyloid Burden in Transthyretin AmyloidosisAwais Sheikh, Anouk Achten, Alberto Aimo, et al.
NEJM Evidence|February 6, 2024
A Pragmatic Randomized Feasibility Trial of Influenza VaccinesNiklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
Circulation. Heart Failure|October 27, 2023
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVERToru Kondo, Jawad H Butt, James P Curtain, et al.
European Heart Journal|March 4, 2026
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term studyAlbree Tower-Rader, Ahmad Masri, Michael E Nassif, et al.
JAMA Cardiology|March 28, 2026
Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical TrialHenri Lu, Annamaria Kosztin, Brian L Claggett, et al.
JACC. Heart Failure|September 28, 2023
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER TrialAlexander Peikert, Bradley A Bart, Muthiah Vaduganathan, et al.
JACC. Heart Failure|November 17, 2020
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
Pageof 188